Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.61M Hold
9,900
0.15% 122
2026
Q1
$3.74M Hold
9,900
0.13% 119
2025
Q4
$4.24M Hold
9,900
0.14% 108
2025
Q3
$4.43M Hold
9,900
0.15% 104
2025
Q2
$4.82M Buy
9,900
+3,400
+52% +$1.94M 0.18% 95
2025
Q1
$4M Buy
6,500
+500
+8% +$284K 0.18% 86
2024
Q4
$3.18M Hold
6,000
0.14% 85
2024
Q3
$3.61M Sell
6,000
-500
-8% -$283K 0.16% 82
2024
Q2
$3.53M Buy
6,500
+1,200
+23% +$687K 0.16% 78
2024
Q1
$3.4M Hold
5,300
0.16% 82
2023
Q4
$3.1M Hold
5,300
0.15% 87
2023
Q3
$2.75M Buy
5,300
+2,500
+89% +$1.3M 0.16% 85
2023
Q2
$1.52M Buy
+2,800
New +$1.53M 0.08% 104

Other funds holding CHE

Covea Finance's CHE Position: Q2 2026 in Review

Covea Finance held its Chemed (CHE) position steady in Q2 2026 at 9,900 shares worth $4.61M. The position accounts for 0.15% of the portfolio, ranked #122.

Covea Finance first reported a position in CHE in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.82M in Q2 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Covea Finance held 9,900 shares of Chemed worth $4.61M as of Q2 2026.
  • Covea Finance left its Chemed share count unchanged in Q2 2026.
  • Chemed made up 0.15% of Covea Finance's portfolio in Q2 2026, its #122 holding.
  • Covea Finance first reported a position in Chemed in Q2 2023 and has held it in 13 quarters since.
  • Covea Finance's Chemed position peaked at $4.82M in Q2 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.